Elucidating the specific pharmacological mechanism of motion (MOA) of The natural way developing compounds could be complicated. Whilst Tarselli et al. (60) developed the 1st de novo synthetic pathway to conolidine and showcased that this In a natural way occurring compound correctly suppresses responses to each chemically induced and inflammation-